Mylan Can’t Escape Purdue OxyContin Patent Suit

Mylan Pharmaceuticals Inc. likely will have to continue to face Purdue Pharma LP’s infringement claims over its proposed generic OxyContin product (Purdue Pharma, LP v. Mylan Pharm., Inc., 2017 BL 62928, D. Del., No. 1:15-cv-1155, 3/1/17).

Mylan’s bid to have the suit thrown out was rejected March 1 when U.S. Magistrate Judge Sherry R. Fallon of the U.S. District Court for the District of Delaware said that because there were still questions of fact to be resolved, ...